GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
37.56
+0.41 (1.10%)
At close: Aug 1, 2025, 4:00 PM
37.50
-0.06 (-0.16%)
After-hours: Aug 1, 2025, 7:39 PM EDT
Augmedix Revenue
GSK had revenue of 7.99B GBP in the quarter ending June 30, 2025, with 1.29% growth. This brings the company's revenue in the last twelve months to 31.63B, up 0.59% year-over-year. In the year 2024, GSK had annual revenue of 31.38B with 3.46% growth.
Revenue (ttm)
31.63B GBP
Revenue Growth
+0.59%
P/S Ratio
1.72
Revenue / Employee
460,898 GBP
Employees
68,629
Market Cap
74.69B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 49.00B |
Novo Nordisk | 43.92B |
GSK News
- 15 hours ago - Pharmaceutical makers were largely unshaken by new demands from President Trump to lower drug prices, with experts saying the measures would either have modes impact or face legal challenges - WSJ
- 1 day ago - Pharma Companies Should Immediately Cut Down Drug Prices, Trump Says - Forbes
- 1 day ago - Trump pressures 17 pharma CEOs to cut US drug prices - Reuters
- 1 day ago - Trump says he asked 17 drugmakers to take steps to cut U.S. prices within 60 days - CNBC
- 2 days ago - GSK plc (GSK) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - GSK in talks with Trump administration on U.S. drug pricing, CEO says - Reuters
- 3 days ago - GSK expects annual sales and profit at top end of forecast range - Reuters
- 4 days ago - GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval - Seeking Alpha